Role of insulin resistance in endothelial dysfunction
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Insulin resistance is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular diseases. Insulin exerts pro- and anti-atherogenic actions on the vasculature. The balance between nitric oxide (NO)-dependent vasodilator actions and endothelin-1- dependent vasoconstrictor actions of insulin is regulated by phosphatidylinositol 3-kinase-dependent (PI3K) - and mitogen-activated protein kinase (MAPK)-dependent signaling in vascular endothelium, respectively. During insulin-resistant conditions, pathway-specific impairment in PI3K-dependent signaling may cause imbalance between production of NO and secretion of endothelin-1 and lead to endothelial dysfunction. Insulin sensitizers that target pathway-selective impairment in insulin signaling are known to improve endothelial dysfunction. In this review, we discuss the cellular mechanisms in the endothelium underlying vascular actions of insulin, the role of insulin resistance in mediating endothelial dysfunction, and the effect of insulin sensitizers in restoring the balance in pro- and anti-atherogenic actions of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“NO can enhance insulin sensitivity by activating insulin receptor substrates and downstream signalling molecules, such as Akt and mTOR, which are involved in protein synthesis in muscle82.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [82]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535 · cited 1×
“Insulin resistance plays a patho-physiological role in type 2 diabetes and is frequently present in obesity, hypertension, coronary artery disease, dyslipidemias, and metabolic syndrome [1, 2].”
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · cited 1×
“Calorie restriction improves NO-dependent vasodilation and simulatenously reduces circulating ET-1 levels in insulin resistant individuals [70–72].”
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200 · cited 1×
“Importantly, endothelial dysfunction is independently associated with and predicts cardiac death, myocardial infarction, and stroke [13].”
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“Relationship between insulin resistance and endothelial dysfunction: a meta-analysis Many cross-sectional studies have examined the relationship between insulin resistance/ sensitivity and endothelial function [7, 43–56].”
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652 · cited 1×
“to reciprocal relationships between insulin resistance and endothelial dysfunction that foster the clustering of metabolic and cardiovascular diseases in insulin-resistant states [8].”
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
Williams, S. B., Cusco, J. A., Roddy, M.-A., Johnstone, M. T., & Creager, M. A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00522-6 · Cited by 1,014
Bonetti, P. O., Pumper, G. M., Higano, S. T., Holmes, D. R., Kuvin, J. T., & Lerman, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.062 · Cited by 973 · cited 1×
“Endothelial function measured using this technique correlates well with coronary endothelial-mediated vasodilatory response to acetylcholine [16].”
Cited by
Insulin resistance, cardiovascular stiffening and cardiovascular disease
Hill, M. A., Yang, Y., Zhang, L., Sun, Z., Jia, G., Parrish, A. R., & Sowers, J. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154766 · Cited by 1,045
Self-citationEndothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Kaur, R., Kaur, M., & Singh, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0763-3 · Cited by 736
“Insulin resistance also increases expression of PAI-1, a coagulant tissue factor and adhesion molecules [62].”
BackgroundRamos, J. S., Dalleck, L. C., Tjonna, A. E., Beetham, K. S., & Coombes, J. S. (2015) · Sports Medicine · doi:10.1007/s40279-015-0321-z · Cited by 715
“It promotes vascular homeostasis through its ability to stimulate signaling pathways, which could regulate both NO [phosphoinositide 3-kinase (PI3K)/Akt pathway] and endothelin-1 [mitogenactivated protein kinases (MAPK) pathway] production [12].”
BackgroundJung, E., Romero, R., Yeo, L., Gomez-Lopez, N., Chaemsaithong, P., Jaovisidha, A., Gotsch, F., & Erez, O. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1356 · Cited by 552
Metadata
- Authors
- Muniyappa, R., & Sowers, J. R.
- Affiliations
- National Institutes of Health (US)
- Harry S. Truman Memorial Veterans' Hospital (US)
- Corresponding author
- Sowers, James R.
- Venue
- Reviews in Endocrine and Metabolic Disorders
- Published
- 2013-01-10
- Volume
- 14
- Issue
- 1
- Pages
- 5-12
- ISSN
- 1389-9155 (ISSN-L)
- 1573-2606
- PMC
- PMC3594115
- OpenAlex
- W1975628529
- Cited by
- 539
- References
- 81
- Citations by year
- 2026: 60 · 2025: 62 · 2024: 57 · 2023: 30 · 2022: 41 · 2021: 36 · 2020: 52 · 2019: 38 · 2018: 47 · 2017: 28 · 2016: 25 · 2015: 29 · 2014: 21 · 2013: 13
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Reviews in Endocrine and Metabolic Disorders (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5r01hl107910-03)
- National Heart, Lung, and Blood Institute (R01 HL107910-03, R01-HL-107910, R01HL073101, R01 HL73101-08)
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- insulin resistance, endothelial dysfunction, insulin signaling, nitric oxide, endothelin-1, PI3K signaling, MAPK signaling, insulin sensitizers, atherosclerosis, vascular endothelium, cardiovascular disease
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Insulin Resistance, Nitric Oxide, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of insulin resistance in endothelial dysfunction. https://app.cochat.ai/papers/10.1007/s11154-012-9229-1
- The paper
- Muniyappa, R., & Sowers, J. R. (2013). Role of insulin resistance in endothelial dysfunction. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-012-9229-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.